13F

Stock

ARS Pharmaceuticals, Inc.

SPRY · held by 3 managers

Reported value

$11.4M

Holders

3

+0 new · −0 exited

Holders’ est. mark

$643K

Price effect on 1 books still in the name

Largest holder

$10.9M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC622.2K$10.9M$643KAdded$9.2M
Cresset Asset Management, LLC30.2K$526.2KHeld
Essential Partners LLC57$995Held

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.